Concept
Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19 (United States)
- This paper details the interactions f asthma and COVID-19 in the United States
- Due to limited data, it is difficult to pinpoint whether asthma puts someone at an increased risk for COVID-19 infection
- This study looks to determine the prevalence of asthma and asthma related comorbidities and COVID-19 as well as generally evaluate the hospitalization rates of COVID-19 patients with and without asthma
- Though most of the data for this study was able to be automated, to confirm asthma diagnoses in COVID-19 patients, all automatically flagged asthma charts in the database were manually checked as well
- It was generally found that out of the 1526 patients whose criteria met study guidelines, 14.4% (220) had asthma
- The prime demographic for asthma and COVID-19 was the 40-69 year old group (55.3%), and the predominant sub group of this was patients who claimed to be non-Hispanic African American (35.5%)
- Platelet count in non-asthmatic patients was significantly lower than those with asthma
- Lab values taken during the study indicate that patients with asthma and COVID-19 had significantly lower levels of ferritin, C-reactive protein, and lactate dehydrogenase
0
1
Updated 2020-09-15
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences